BSI response to the All-Party Parliamentary Group (APPG) on Diversity and Inclusion in STEM report on the state of diversity and inclusion in STEM workforce.
Read our response to the report from Academy of Medical Sciences on winter planning for 2021/22.
The Psoriasis and Psoriatic Arthritis Alliance has joined Connect Immune Research, an initiative designed to bring about a critical change in the way autoimmune conditions are researched. The BSI is a supporting partner of this initiative, along members JDRF, the MS Society, Versus Arthritis and Alopecia UK.
BSI response to study on AstraZeneca/Oxford vaccine and rare autoimmune bleeding disorder known as idiopathic thrombocytopenic purpura (ITP).
A new study has found that many patients with COVID-19 produce immune responses against their body’s own tissues or organs. The paper was published in Clinical & Experimental Immunology.
BSI response to approval of the Janssen COVID-19 vaccine by the MHRA for use in the UK.
British Society for Immunology response to new repot from the All Party Parliamentary Group (APPG) on Vaccinations For All looking into the factors that improve or hinder vaccine uptake.
BSI response to first blood plasma donations for medicines starting today
BSI response to MHRA and JCVI updates on AstraZeneca/Oxford COVID-19 vaccine
British Society for Immunology statement in response to cuts to the UK's science budget
BSI response to announcements from EMA and MHRA on AstraZeneca/Oxford COVID-19 vaccine and blood clots
British Society for Immunology response to new Public Health England data on COVID vaccine effectiveness
British Society for Immunology response to the Government lifting a ban on UK-sourced blood plasma being used in the manufacture of life-saving medicines, known as immunoglobulins.
BSI response to new pre-print study on the effect of the first dose of the Pfizer/BioNTech and the Oxford/AstraZeneca vaccines on preventing severe illness resulting in hospitalisation in Scotland.
British Society for Immunology response to data from Israel on the effectiveness of the Pfizer/BioNTech vaccine after one dose in healthcare workers.